578. Infections in Patients Treated with Chimeric Antigen Receptor T-cells (CAR-T) therapy

BACKGROUND: Although chimeric antigen receptor T cells (CAR-T) is a promising novel therapy for the treatment of relapsed or refractory (R/R) B-cell malignancies, data on infectious complications associated with this therapy are limited. Therefore, further assessment of infections after CAR-T therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Nikki, Eschenauer, Gregory, Scappaticci, Gianni, Frame, David, Miceli, Marisa H, Patel, Twisha S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777222/
http://dx.doi.org/10.1093/ofid/ofaa439.772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777222/
http://dx.doi.org/10.1093/ofid/ofaa439.772

Ejemplares similares